Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book reports on the latest research and developments in Biomedical Engineering, with a special emphasis on topics of interest and findings achieved in Latin America. This fourth volume of a 4-volume set focuses on health technology assessment, quality of healthcare technologies, and innovation in health technologies. It discusses advances in medical device monitoring, issues in patient safety, methods for medical error analysis and medical data management, and other related topics. Throughout the book, a special emphasis is given to low-cost technologies and to their development for and applications in clinical settings. Based on the IX Latin American Conference on Biomedical Engineering (CLAIB 2022) and the XXVIII Brazilian Congress on Biomedical Engineering (CBEB 2022), held jointly, and virtually on October 24-28, 2022, from Florianópolis, Brazil, this book provides researchers and professionals in the biomedical engineering field with extensive information on new technologies and current challenges for their clinical applications.

Biomedical engineering. --- Health services administration. --- Industrial Management. --- Medical and Health Technologies. --- Health Care Management. --- Biomedical engineering

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This volume demonstrates advanced strategies in biomedical sciences and healthcare focused on suboptimal health conditions in the framework of Predictive, Preventive and Personalised Medicine (3PM/PPPM). Potential benefits in healthcare systems and for society at large include but are not restricted to an improved life-quality of major populations and socio-economical groups, advanced professionalism of healthcare-givers and sustainable healthcare economy. Reactive medical services applied to healthcare resulted in epidemics of non-communicable diseases such as diabetes mellitus type 2 with currently about a half of billion patients registered worldwide. Far-reaching consequences are cascading co-morbidities with poor prognosis such as severe cardiovascular and neurological disorders, eye pathologies (e.g., proliferative diabetic retinopathy as the world leading cause of blindness) and several types of cancer, amongst others. Corresponding socio-economic burden is tremendous. The paradigm changes from reactive medicine to PPPM propagated by EPMA is, therefore, pivotal for advanced healthcare to improve the economy of medical services, life quality of populations and individual outcomes. To this end, individuals with suboptimal health condition comprise the target group for predictive diagnostics and cost-effective personalised treatments to protect affected individuals and sub-populations against health-to-disease transition, a window of opportunity for PPPM. This goal is of highest priority benefiting millions of people and societies at large.

Medicine, Preventive. --- Health promotion. --- Health services administration. --- Primary care (Medicine). --- Medicine --- Biology --- Health Promotion and Disease Prevention. --- Health Care Management. --- Primary Care Medicine. --- Translational Research. --- Research.